Apnimed, Inc. (APMD)
14.40
+0.24
(+1.69%)
USD |
NASDAQ |
Nov 06, 10:08
Apnimed Gross Profit Margin (Quarterly) : 89.98% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 89.98% |
| March 31, 2026 | 97.45% |
| Date | Value |
|---|---|
| June 30, 2025 | 89.92% |
| March 31, 2025 | 57.94% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| IGC Pharma, Inc. | 2.64% |
| Cocrystal Pharma, Inc. | 88.57% |
| CNBX Pharmaceuticals, Inc. | -- |
| Arvinas, Inc. | -140.0% |
| Fulcrum Therapeutics, Inc. | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Operating Margin (Quarterly) | -96.89% |